Fengling Luo

1.3k total citations
34 papers, 1.0k citations indexed

About

Fengling Luo is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Fengling Luo has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Fengling Luo's work include Tuberculosis Research and Epidemiology (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Immune cells in cancer (4 papers). Fengling Luo is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Immune cells in cancer (4 papers). Fengling Luo collaborates with scholars based in China, United States and Japan. Fengling Luo's co-authors include Xiao‐Lian Zhang, Qin Pan, Mohammed Ali Al-Bayati, Jing Zhou, Fan Chen, Jun Yan, Min Liu, Sabrin Albeituni, Xiao Hu and Michael Bousamra and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fengling Luo

32 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengling Luo China 16 483 425 157 135 122 34 1.0k
Paul Costeas Cyprus 19 411 0.9× 316 0.7× 166 1.1× 105 0.8× 46 0.4× 47 1.4k
Mohammad M. Pourseif Iran 18 621 1.3× 159 0.4× 91 0.6× 142 1.1× 89 0.7× 35 1.1k
Tao Hu China 22 630 1.3× 165 0.4× 124 0.8× 169 1.3× 126 1.0× 93 1.3k
Eric L. Schneider United States 19 465 1.0× 188 0.4× 90 0.6× 242 1.8× 92 0.8× 40 1.4k
Julien Fassy France 8 275 0.6× 301 0.7× 100 0.6× 115 0.9× 78 0.6× 12 823
Zhifang Zhou China 19 701 1.5× 337 0.8× 66 0.4× 87 0.6× 149 1.2× 50 1.1k
Elżbieta Pajtasz‐Piasecka Poland 17 282 0.6× 373 0.9× 57 0.4× 63 0.5× 57 0.5× 59 760
Sylvain Lehoux United States 20 814 1.7× 336 0.8× 66 0.4× 80 0.6× 76 0.6× 32 1.2k
Stefanie N. Vogel United States 16 488 1.0× 262 0.6× 74 0.5× 128 0.9× 116 1.0× 21 981
Charles G. Garlisi United States 22 337 0.7× 430 1.0× 84 0.5× 87 0.6× 127 1.0× 42 1.4k

Countries citing papers authored by Fengling Luo

Since Specialization
Citations

This map shows the geographic impact of Fengling Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Luo more than expected).

Fields of papers citing papers by Fengling Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengling Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Luo. The network helps show where Fengling Luo may publish in the future.

Co-authorship network of co-authors of Fengling Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Fengling Luo. A scholar is included among the top collaborators of Fengling Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengling Luo. Fengling Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
4.
Tan, Yujia, Fengling Luo, Yongchang Wei, & Pan Liu. (2024). Application of proteomics in brain's aging research. 2(3). 1 indexed citations
5.
6.
Luo, Fengling, et al.. (2022). EST12 regulates Myc expression and enhances anti-mycobacterial inflammatory response via RACK1-JNK-AP1-Myc immune pathway. Frontiers in Immunology. 13. 943174–943174. 10 indexed citations
7.
Liu, Min, Zan Tong, Chuanlin Ding, et al.. (2020). Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer. Journal of Clinical Investigation. 130(4). 2081–2096. 129 indexed citations
8.
Luo, Wei, Lingyun Zhang, Yan Xie, et al.. (2018). Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses. Vaccine. 36(21). 2998–3009. 7 indexed citations
9.
Pan, Qin, Fengling Luo, Min Liu, & Xiao‐Lian Zhang. (2018). Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases. Journal of Infection. 77(2). 83–98. 43 indexed citations
10.
Luo, Fengling, Tielong Chen, Jun Liu, et al.. (2016). Ficolin-2 binds to HIV-1 gp120 and blocks viral infection. Virologica Sinica. 31(5). 406–414. 16 indexed citations
11.
Luo, Fengling, Xiaoming Sun, Zhen Qu, & Xiao‐Lian Zhang. (2016). Salmonella typhimurium-induced M1 macrophage polarization is dependent on the bacterial O antigen. World Journal of Microbiology and Biotechnology. 32(2). 22–22. 14 indexed citations
12.
Zhang, Dingyu, et al.. (2014). miR-141 targets ZEB2 to suppress HCC progression. Tumor Biology. 35(10). 9993–9997. 33 indexed citations
13.
Pan, Qin, Qilong Wang, Xiaoming Sun, et al.. (2014). Aptamer Against Mannose-capped Lipoarabinomannan Inhibits Virulent Mycobacterium tuberculosis Infection in Mice and Rhesus Monkeys. Molecular Therapy. 22(5). 940–951. 56 indexed citations
14.
Luo, Fengling, Xiaoming Sun, Yubin Wang, et al.. (2013). Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans. PLoS ONE. 8(9). e73859–e73859. 59 indexed citations
15.
Huang, Rong, Shengyong Yan, Xiaolong Zheng, et al.. (2012). Development of a pH-activatable fluorescent probe and its application for visualizing cellular pH change. The Analyst. 137(19). 4418–4418. 25 indexed citations
16.
Chen, Fang, Yinglan Zhao, Min Liu, et al.. (2010). Functional Selection of Hepatitis C Virus Envelope E2-Binding Peptide Ligands by Using Ribosome Display. Antimicrobial Agents and Chemotherapy. 54(8). 3355–3364. 8 indexed citations
17.
Ma, Yunfeng, et al.. (2009). IL‐24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells. European Journal of Immunology. 39(12). 3357–3368. 41 indexed citations
18.
Li, Guorui, Jun Liu, Qin Pan, et al.. (2009). Synthesis and Anti‐HIV Activity of [ddN]‐[ddN] Dimers and Benzimidazole Nucleoside Dimers. Chemistry & Biodiversity. 6(12). 2200–2208. 6 indexed citations
19.
Liu, Min, Haidan Chen, Fengling Luo, et al.. (2007). Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses. Vaccine. 25(36). 6572–6580. 35 indexed citations
20.
Luo, Fengling, et al.. (2004). Construction of Prokaryotic Recombinant Vector of SARS Coronavirus N Protein and its Expression. The Journal of Microbiology. 24(5). 40–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026